首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1967822

2026-2034年全球心臟节律管理设备市场规模、份额、趋势和成长分析报告

Global Cardiac Rhythm Management Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: 2026年02月05日 | 出版商:

Value Market Research | 英文 142 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

预计到 2034 年，心臟节律管理设备的市场规模将从 2025 年的 279.5 亿美元成长至 449.8 亿美元，2026 年至 2034 年的复合年增长率为 5.43%。

全球心臟节律管理（CRM）市场，包括起搏器、植入式心臟整流去颤器（ICD）和心臟再同步治疗设备，由于人口老化和心律不整筛检的增加而持续成长。设备小型化、电池寿命延长和无导线起搏器技术的进步正在扩大临床应用，而远端监测能力的提升则增强了植入后的护理。此外，新兴市场心血管疾病盛行率的上升和心臟护理服务的改善也推动了这一增长。

关键成长要素包括人口老化、心臟衰竭和心律不整盛行率上升、诊断流程改善以及器械治疗报销范围扩大。技术创新（无导线起搏、皮下植入式ICD、MRI相容设备和先进遥测技术）减少了手术併发症，并提高了患者的生活品质。此外，与数位健康平台和数据分析的互通性实现了早期疗育和优化治疗管理，从而影响了临床医生对现代CRM系统的偏好。

展望未来，重点将放在个人化治疗、持续小型化以及与远距患者管理的整合。无导线多心室节律器、长寿命电池或能源采集解决方案以及人工智慧驱动的心律不整检测技术将定义下一代产品的形式。在新兴市场，随着基础设施和专家的扩展，销售额预计将会成长。由于价格压力、监管审查的加强以及来自微创替代疗法的竞争，製造商必须专注于临床差异化、疗效数据和基于价值的合同，以维持长期增长。

区域分析
北美市场分析、洞察与预测
- 我们
- 加拿大
- 墨西哥
欧洲市场分析、洞察与预测
- 英国
- 法国
- 德国
- 义大利
- 俄罗斯
- 其他欧洲国家
亚太市场分析、洞察与预测
- 印度
- 日本
- 韩国
- 澳洲
- 东南亚
- 其他亚太国家
拉丁美洲市场分析、洞察与预测
- 巴西
- 阿根廷
- 秘鲁
- 智利
- 其他拉丁美洲国家
中东和非洲市场分析、洞察与预测
- 沙乌地阿拉伯
- UAE
- 以色列
- 南非
- 其他中东和非洲国家

第八章竞争情势

最新趋势
公司分类
供应链和销售管道合作伙伴（根据现有资讯）
市场占有率和市场定位分析（基于现有资讯）
供应商情况（基于现有资讯）
策略规划

第九章：公司简介

主要公司的市占率分析
公司简介
- Abbott Laboratories
- Abiomed Inc
- AMI Italia SRL
- Asahi Kasei Corporation
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- BPL Medical Technologies
- CU Medical Inc
- Defibtech LLC
- LivaNova Plc
- Medico GmbH

简介目录

Product Code: VMR11218634

The Cardiac Rhythm Management Devices Market size is expected to reach USD 44.98 Billion in 2034 from USD 27.95 Billion (2025) growing at a CAGR of 5.43% during 2026-2034.

The global cardiac rhythm management (CRM) market, encompassing pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy devices, has expanded due to aging populations and greater screening for arrhythmias. Advances in device miniaturization, battery longevity, and leadless pacemaker technologies have broadened clinical adoption, while remote monitoring capabilities have improved post-implant care. Growth has been further supported by rising cardiovascular disease prevalence and better access to cardiac care in emerging markets.

Major growth drivers include demographic aging, increasing prevalence of heart failure and arrhythmias, improved diagnostic pathways, and reimbursement expansions for device therapies. Technological innovations-leadless pacing, subcutaneous ICDs, MRI-conditional devices, and enhanced telemetry-reduce procedural complications and enhance patient quality of life. Additionally, interoperability with digital health platforms and data analytics enables earlier intervention and optimized therapy management, influencing clinician preference toward modern CRM systems.

Future outlook emphasizes personalized therapies, continued miniaturization, and integration with remote patient management. Leadless multi-chamber pacing, longer-life batteries or energy-harvesting solutions, and AI-driven arrhythmia detection will shape next-generation offerings. Emerging markets will contribute incremental sales as infrastructure and trained specialists expand. Pricing pressures, regulatory scrutiny, and competition from minimally invasive alternatives will require manufacturers to focus on clinical differentiation, outcomes data, and value-based contracting to sustain long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

Pacemakers
Defibrillators
Cardiac Resynchronization Therapy Devices

By Application

Congestive Heart Failure
Arrhythmias
Bradycardia
Tachycardia
Other Applications

By End Use

Hospitals
Cardiac Care Centers
Ambulatory Surgical Centers
Other End Use

COMPANIES PROFILED

Abbott Laboratories, Abiomed Inc, AMI Italia Srl, Asahi Kasei Corporation, Biotronik SE Co KG, Boston Scientific Corporation, BPL Medical Technologies, CU Medical Inc, Defibtech LLC, LivaNova plc, Medico GmbH
We can customise the report as per your requirements.

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Product
4.2. Pacemakers Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Defibrillators Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Cardiac Resynchronization Therapy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Application
5.2. Congestive Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Arrhythmias Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Bradycardia Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Tachycardia Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY END USE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast End Use
6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Cardiac Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Other End Use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY REGION 2022-2034(USD MN)

7.1. Regional Outlook
7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product
- 7.2.2 By Application
- 7.2.3 By End Use
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product
- 7.3.2 By Application
- 7.3.3 By End Use
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product
- 7.4.2 By Application
- 7.4.3 By End Use
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product
- 7.5.2 By Application
- 7.5.3 By End Use
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product
- 7.6.2 By Application
- 7.6.3 By End Use
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

8.1. Recent Developments
8.2. Company Categorization
8.3. Supply Chain & Channel Partners (based on availability)
8.4. Market Share & Positioning Analysis (based on availability)
8.5. Vendor Landscape (based on availability)
8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Company Profiles
- 9.2.1 Abbott Laboratories
- 9.2.2 Abiomed Inc
- 9.2.3 AMI Italia S.R.L
- 9.2.4 Asahi Kasei Corporation
- 9.2.5 Biotronik SE & Co. KG
- 9.2.6 Boston Scientific Corporation
- 9.2.7 BPL Medical Technologies
- 9.2.8 CU Medical Inc
- 9.2.9 Defibtech LLC
- 9.2.10 LivaNova Plc
- 9.2.11 Medico GmbH

02-2729-4219

+886-2-2729-4219

License/价格

2026-2034年全球心臟节律管理设备市场规模、份额、趋势和成长分析报告

Global Cardiac Rhythm Management Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034